Do the Neonatal Pain Agitation and Sedation Scale (N-PASS) and the Richmond Agitation-Sedation Scale (RASS) have the same target for neonates under 2 months of age in the Neonatal Intensive Care Unit (NICU)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

N-PASS and RASS Target Sedation Goals Are Not the Same

The N-PASS (Neonatal Pain, Agitation and Sedation Scale) and RASS (Richmond Agitation-Sedation Scale) are fundamentally different tools designed for different patient populations with different target ranges—N-PASS is validated for neonates and does not have the same numerical targets as RASS, which is designed for adults. 1, 2

Key Differences Between the Scales

Population and Validation

  • RASS is validated exclusively for adult ICU patients and provides the most valid and reliable sedation assessment in this population, with excellent inter-rater reliability (r = 0.956). 1, 3
  • N-PASS is specifically designed and validated for neonates (0-100 days of age, gestational age 23-40 weeks) in the NICU setting, assessing both pain/agitation and sedation. 2, 4
  • The American Academy of Pediatrics recommends N-PASS for measuring neonatal pain and sedation, while the Society of Critical Care Medicine recommends RASS for adult ICU patients. 3, 2

Scale Structure and Scoring

  • RASS uses a 10-point scale ranging from +4 (combative) to -5 (unarousable), with the target for most mechanically ventilated adults being RASS -2 to 0 (light sedation to awake and calm). 1, 3
  • N-PASS has separate pain/agitation and sedation subscales with different scoring systems that incorporate both behavioral and physiological indicators specific to neonatal responses. 2, 5, 4
  • N-PASS demonstrates high interrater reliability (ICC 0.85-0.95) and internal consistency (Cronbach's alpha 0.82 for pain, 0.87 for sedation) in neonates. 4

Why Direct Comparison Is Inappropriate

Developmental Differences

  • Neonates cannot self-report pain and require multidimensional assessment tools combining physiologic indicators (heart rate, respiratory rate, blood pressure, oxygen saturation) and behavioral indicators (facial expressions, body movements, crying, sleep patterns). 1, 6
  • Neonates show fundamentally different pain responses than adults, including altered physiologic patterns during prolonged pain (passivity, decreased heart rate variability, energy conservation). 1
  • Preterm neonates are particularly vulnerable, experiencing 10.0-22.9 painful procedures per day, with repeated exposures causing permanent neuroanatomic changes and altered pain sensitivity lasting into adolescence. 1, 6

Clinical Context Differences

  • For adults, RASS targets light sedation (RASS -2 to 0) to reduce mechanical ventilation duration and ICU length of stay while maintaining safety. 3
  • For neonates, the ESPNIC guidelines recommend age-appropriate tools like PIPP-R for pain assessment rather than sedation depth scales like RASS. 1
  • The COMFORT-B scale and FLACC scale are recommended for infants and children in PICU settings, not RASS. 1

Critical Clinical Pitfalls

Avoid Cross-Population Application

  • Never use RASS in neonates under 2 months as it lacks validation in this population and does not account for neonatal-specific pain responses. 1
  • Never assume N-PASS targets translate to RASS equivalents as the scales measure different constructs with different scoring systems. 2, 4
  • N-PASS has demonstrated validity for mechanically ventilated neonates and postoperative pain, but lacks support for measuring prolonged pain in nonventilated infants. 2

Assessment Priorities in Neonates

  • Always use multidimensional assessment rather than relying solely on vital signs, as behavioral indicators are more reliable than physiologic measures alone in neonates. 1
  • Minimize total procedural exposure as the most effective pain reduction strategy, rather than focusing solely on sedation depth targets. 1, 6
  • Implement nonpharmacologic interventions first (oral sucrose, breastfeeding, kangaroo care) for routine procedures before escalating to pharmacologic management. 1, 6

Staff Training Requirements

  • Each neonatal unit must provide continual multidisciplinary training in neonatal pain recognition and proper use of N-PASS, as the scale requires expertise in interpreting neonatal-specific behavioral and physiologic responses. 1, 6, 4
  • Bedside nurses demonstrate very strong agreement with N-PASS sedation scores (κ = 0.99) when properly trained, with 93% reporting the scale reflects infant sedation well or very well. 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Neonatal Pain, Agitation, and Sedation Scale's use, reliability, and validity: a systematic review.

Journal of perinatology : official journal of the California Perinatal Association, 2020

Guideline

RASS Score-Based Treatment Adjustment in ICU Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical reliability and validity of the N-PASS: neonatal pain, agitation and sedation scale with prolonged pain.

Journal of perinatology : official journal of the California Perinatal Association, 2008

Research

Agreement of the Neonatal Pain, Agitation, and Sedation Scale (N-PASS) With NICU Nurses' Assessments.

Advances in neonatal care : official journal of the National Association of Neonatal Nurses, 2023

Guideline

Managing Distress in Newborns

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.